K. Okita

Molecular Biology · 2007–2017

A researcher in the Science corpus: 15 papers; trusts 4 researchers and is trusted by 22 researchers here, as inferred from the citation graph.

Subfields

Whom K. Okita trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Kazutoshi Takahashi
  2. S. Yamanaka
  3. Tongbiao Zhao
  4. T. Ichisaka
  5. J. Hanna
  6. Marius Wernig
  7. Zhen-Ning Zhang

Who trusts K. Okita overall

  1. M. Stadtfeld
  2. S. Yamanaka
  3. K. Hochedlinger
  4. Kazutoshi Takahashi
  5. Y. Yoshida
  6. Chaomei Chen
  7. Hiroyuki Sasaki
  8. José C. R. Silva
  9. Nimet Maherali
  10. K. Yusa

Papers from K. Okita's perspective

Ordered by how strongly the researchers K. Okita trusts endorse each paper. Same corpus, a different order for every researcher.

  1. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state (Nature)
  2. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. (Cell Stem Cell)
  3. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. (Cell Stem Cell)
  4. Low O2 tensions and the prevention of differentiation of hES cells. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo (Nature)
  6. A specific amyloid-β protein assembly in the brain impairs memory (Nature)
  7. Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss (Proceedings of the National Academy of Sciences of the United States of America)
  8. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. (Archives of Neurology)
  9. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide (Nature reviews. Molecular cell biology)
  10. Neurodegenerative diseases and oxidative stress (Nature reviews. Drug discovery)

Their papers